Co-Authors
This is a "connection" page, showing publications co-authored by Francesco Ferrara and Raffaele Porta.
Connection Strength
0.917
-
COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view. Ir J Med Sci. 2022 Feb; 191(1):487-488.
Score: 0.233
-
Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks? Ir J Med Sci. 2021 Nov; 190(4):1637-1638.
Score: 0.231
-
Remdesivir and COVID-19. Ir J Med Sci. 2021 08; 190(3):1237-1238.
Score: 0.227
-
Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times? Indian J Pharmacol. 2020 Sep-Oct; 52(5):441-442.
Score: 0.225